Evidence map›Paper›PMID 24938399›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2014

3-Nitropropionic acid-induced ischemia tolerance in the rat brain is mediated by reduced metabolic activity and cerebral blood flow.

Oliver Bracko, Valentina Di Pietro, Giacomo Lazzarino, Angela M Amorini, Barbara Tavazzi, Judith Artmann, Eric C Wong, Richard B Buxton, Michael Weller, Andreas R Luft and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. ILBJournal of personalized medicine · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Oliver BrackoDepartment of Neurology, University Hospital Zurich, Zurich, Switzerland.
Valentina Di PietroDivision of Neurotrauma and Neurodegeneration, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK.
Giacomo LazzarinoInstitute of Biochemistry and Clinical Biochemistry, Catholic University of Rome, Rome, Italy.
Angela M AmoriniInstitute of Biochemistry and Clinical Biochemistry, Catholic University of Rome, Rome, Italy.
Barbara TavazziInstitute of Biochemistry and Clinical Biochemistry, Catholic University of Rome, Rome, Italy.
Judith ArtmannDepartment of Neurology, University Hospital Zurich, Zurich, Switzerland.
Eric C Wong1] Departments of Radiology, University of California San Diego, La Jolla, California, USA [2] Departments of Psychiatry, University of California San Diego, La Jolla, California, USA.
Richard B BuxtonDepartments of Radiology, University of California San Diego, La Jolla, California, USA.
Michael WellerDepartment of Neurology, University Hospital Zurich, Zurich, Switzerland.
Andreas R LuftDepartment of Neurology, University Hospital Zurich, Zurich, Switzerland.
Susanne WegenerDepartment of Neurology, University Hospital Zurich, Zurich, Switzerland.
University Hospital of Zurich · CHUniversità Cattolica del Sacro Cuore · ITUniversity of California, San Diego · USUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue tolerance to ischemia can be achieved by noxious stimuli that are below a threshold to cause irreversible damage ('preconditioning'). Understanding the mechanisms underlying preconditioning may lead to the identification of novel therapeutic targets for diseases such as stroke. We here used the oxidative chain inhibitor 3-nitropropionic acid (NPA) to induce ischemia tolerance in a rat middle cerebral artery occlusion (MCAO) stroke model. Cerebral blood flow (CBF) and structural integrity were characterized by longitudinal magnetic resonance imaging (MRI) in combination with behavioral, histologic, and biochemical assessment of NPA-preconditioned animals and controls. Using this approach we show that the ischemia-tolerant state is characterized by a lower energy charge potential and lower CBF, indicating a reduced baseline metabolic demand, and therefore a cellular mechanism of neural protection. Blood vessel density and structural integrity were not altered by NPA treatment. When subjected to MCAO, preconditioned animals had a characteristic MRI signature consisting of enhanced CBF maintenance within the ischemic territory and intraischemic reversal of the initial cytotoxic edema, resulting in reduced infarct volumes. Thus, our data show that tissue protection through preconditioning occurs early during ischemia and indicate that a reduced cellular metabolism is associated with tissue tolerance to ischemia.

Indexed as

Brain IschemiaStrokeAnimalsAntihypertensive AgentsCerebral AngiographyCerebrovascular CirculationDisease Models, AnimalIschemic PreconditioningMagnetic Resonance AngiographyNeuroprotective AgentsNitro CompoundsPropionatesRats3-nitropropionic acidAntihypertensive AgentsNeuroprotective AgentsNitro CompoundsPropionates

Identifiers

PMID24938399
PMCPMC4158668
OpenAlexW2075275630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.